Hester Biosciences Ltd vs Orchid Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Hester Biosciences Ltd is ₹ 1960 as of 12 Jun 15:30 . The P/E Ratio of Hester Biosciences Ltd changed from 47.4 on March 2021 to 38.8 on March 2025 . This represents a CAGR of -3.92% over 5 yearsThe P/E Ratio of Orchid Pharma Ltd changed from 33.9 on March 2023 to 39.5 on March 2025 . This represents a CAGR of 5.23% over 3 years The Market Cap of Hester Biosciences Ltd changed from ₹ 1630 crore on March 2021 to ₹ 1066 crore on March 2025 . This represents a CAGR of -8.14% over 5 yearsThe Market Cap of Orchid Pharma Ltd changed from ₹ 10061 crore on March 2021 to ₹ 3940 crore on March 2025 . This represents a CAGR of -17.10% over 5 years The revenue of Hester Biosciences Ltd for the Mar '26 is ₹ 101.88 crore as compare to the Dec '25 revenue of ₹ 79.4 crore. This represent the growth of 28.31% The revenue of Orchid Pharma Ltd for the Mar '26 is ₹ 245.49 crore as compare to the Dec '25 revenue of ₹ 212.88 crore. This represent the growth of 15.32% The ebitda of Hester Biosciences Ltd for the Mar '26 is ₹ 36.1 crore as compare to the Dec '25 ebitda of ₹ 19.78 crore. This represent the growth of 82.51% The ebitda of Orchid Pharma Ltd for the Mar '26 is ₹ 34.75 crore as compare to the Dec '25 ebitda of ₹ 0.06 crore. This represent the growth of 57816% The net profit of Hester Biosciences Ltd changed from ₹ 7.49 crore to ₹ 16.55 crore over 8 quarters. This represents a CAGR of 48.65% The net profit of Orchid Pharma Ltd changed from ₹ 28.27 crore to ₹ 22.79 crore over 8 quarters. This represents a CAGR of -10.21% The Dividend Payout of Hester Biosciences Ltd changed from 21.33 % on March 2021 to 18.71 % on March 2025 . This represents a CAGR of -2.59% over 5 yearsThe Dividend Payout of Orchid Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Hester Biosciences Ltd

Hester Biosciences Limited is one of the leading and pioneering animal healthcare companies in India.
The Company was incorporated in April, 1987 and is engaged in manufacturing of Poultry vaccines and Large Animal Vaccines and trading of Poultry and Large animal and Petcare health products having its manufacturing set up at Meda Adraj Village, Mehsana District, Gujarat. The Company built a presence in several regions of Africa and in numerous nations, including Vietnam, Indonesia, Nepal, and Bangladesh.
The products and services included over 51 vaccines and 70+ health products.
In addition, it offers a vast selection of pharmaceuticals, feed supplements, and disinfectants for poultry and large animals. The Company markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents.

About Orchid Pharma Ltd

Orchid Pharma Limited, is a vertically integrated pharmaceutical company with established research, manufacturing and marketing capabilities across multi-therapeutic domains.
Orchid's world class manufacturing infrastructure include USFDA compliant API and Finished Dosage Form facilities at Chennai in India.
The Company has dedicated state-of-art and GLP compliant R&D infrastructure for Process Research, Drug Discovery and Pharmaceutical Research at Chennai. The Company has a portfolio of antibiotics, and veterinary products.
Antibiotics are life-saving drugs used to ght infections.
Different classes of antibiotics include Beta-lactam, Macrolide, Fluoroquinolone, Imidazoleetc.

FAQs for the comparison of Hester Biosciences Ltd and Orchid Pharma Ltd

Which company has a larger market capitalization, Hester Biosciences Ltd or Orchid Pharma Ltd?

Market cap of Hester Biosciences Ltd is 1,667 Cr while Market cap of Orchid Pharma Ltd is 4,650 Cr

What are the key factors driving the stock performance of Hester Biosciences Ltd and Orchid Pharma Ltd?

The stock performance of Hester Biosciences Ltd and Orchid Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Hester Biosciences Ltd and Orchid Pharma Ltd?

As of June 14, 2026, the Hester Biosciences Ltd stock price is INR ₹1960.4. On the other hand, Orchid Pharma Ltd stock price is INR ₹917.0.

How do dividend payouts of Hester Biosciences Ltd and Orchid Pharma Ltd compare?

To compare the dividend payouts of Hester Biosciences Ltd and Orchid Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.